Session  dedicated to epidemic threats, the situation caused by Sars-CoV-2. Strategies for strengthening  research infrastructures and projects related to epidemiological issues.

Discover the research performed in the field of personalized medicine both in oncological and cardiovascular diseases and the involvment of biobanks in these research projects. Clinical trials on biological drugs used in the treatment of most common oncological and cardiovascular disorders will be presented.

The exposome is a term created to describe the entirety of environmental conditions to which living organisms are exposed, from conception and onward throughout life. In this workshop we ask the question… if biobanks are helping research in other omics, what can biobanks offer as ways to understand the exposome and contribute not just to research, but also to global challenges facing humans and the environment? Please feel warmly welcomed to take part in this workshop, which will be an idea-generating forum and stimulating discussion.

This will be an interactive session where our experts respond to your questions on the impact of GDPR on medical research, the use of human material in national and international projects, and on the idea of a code-of-conduct for biobanks.

The session is intended to show case studies of biobanks working towards or implementing the new ISO standard dedicated to biobanking, 20387.

The session will showcase progress in health research based on the use of prospective population cohorts.

Learn more about research in personalised medicine for cardiovascular diseases and the involvement of biobanks. We are looking for the examples where the research is improving clinical practise, and this may include, for instance clinical trials on biologics for this therapeutic area.

The session will present the examples of the use of botanical biobanks in environmental research and in agricultural development.

This workshop will look at how we share samples more widely. It has long been a vision, and indeed sometimes it works, but not always. What are the challenges, what are the tools, and what are the breakthrough examples that show the value?

Session related to novel IT solutions including basic challenges such as LIMS systems and also software for data analysis.

AI solutions including data analysis, artificial modelling in biomarker/drug development and imaging technologies.

Business and sustainability models are key for running biobanks, especially those which are funded by projects. The aim of the session is to demonstrate various business models in biobanks from Europe and promote more cooperation between public sector biobanks and industry.

Presentation of educational programmes and courses for biobankers. Understand which international or European courses are being offered.

This interactive session aims at facilitating an exchange of thoughts and knowledge about how to tackle some of the most pressing ethical issues we have ahead regarding not only biomedical aspects but also environmental challenges. Kick-started by thought-provoking impulse-presentations, we count on your insights, concerns and experiences to bring different viewpoints to the table.

The session will present the examples of zoological biobanks contributing to species preservation.

This will be an interactive session run in association with the BBMR-ERIC Stakeholder Forum. It will feature perspectives from patients, clinicians and researchers. Building on insights from the last two EBW conferences, it will address the opportunities and challenges of engaging patients more in the whole process from lab-bench to clinic and beyond.

This session will present research projects related to orphan diseases, issues regarding collection of biological samples and data.

This session covers all aspects of the pre-analytical phase, taking account of the needs of research in genomics, transcriptomics, proteomics, metabolomics and on microbiomes.

The session will highlight examples of biobank-based studies addressing specific disease areas and intended to improve current practice in diagnosis or treatment.

Properly designed business models and appropriate cost calculation are key components of well-managed biobanks, while academia-industry collaborations are another opportunity for increasing biobank sustainability. This workshop will look at how we share samples more widely between biobanks and academia as well as biobanks and industry. Meet expertes and exchange ideas, share your concerns!

The session will present the cutting-edge ideas, products, or solutions that could impact samples, biobankers, researchers, patients, and downstream add to a healthier world.

This session is dedicated to automation solutions that improve biobank operation.

This session will showcase how museums work with sample collections to understand evolution and species development and the impact of human activity on the transitions of the biological world.